Yoshikazu Uenosono
Overview
Explore the profile of Yoshikazu Uenosono including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
1983
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baba K, Hozaka Y, Tanabe K, Wada M, Kuroshima N, Takara K, et al.
Asian J Endosc Surg
. 2024 Dec;
18(1):e70007.
PMID: 39710494
Introduction: Regional disparities in medical practice between urban and rural areas in Japan represent a critical issue, and extend to the field of surgical education. To address these disparities, we...
2.
Nakashima T, Arigami T, Uenosono Y, Matsushita D, Shimonosono M, Tsuruda Y, et al.
Int J Clin Oncol
. 2023 Jul;
28(10):1371-1377.
PMID: 37432613
Background: Despite investigations of intraperitoneal paclitaxel as a personalized treatment for peritoneal metastasis of gastric cancer, few studies have evaluated its prognostic impact on conversion surgery for unresectable gastric cancer...
3.
Satake S, Arigami T, Matsushita D, Okubo K, Shimonosono M, Sasaki K, et al.
Oncology
. 2022 Oct;
101(1):12-21.
PMID: 36198262
Introduction: This study aimed to assess the clinical significance of eligibility criteria determined by phase 3 clinical trials in the clinical practice of patients with advanced gastric cancer who underwent...
4.
Impact of Tumor Location on the Quality of Life of Patients Undergoing Total or Proximal Gastrectomy
Fujisaki M, Nomura T, Yamashita H, Uenosono Y, Fukunaga T, Otsuji E, et al.
J Gastric Cancer
. 2022 Aug;
22(3):235-247.
PMID: 35938369
Purpose: Most studies have investigated the differences in postgastrectomy quality of life (QOL) based on the surgical procedure or reconstruction method adopted; only a few studies have compared QOL based...
5.
Arigami T, Matsushita D, Okubo K, Shimonosono M, Sasaki K, Tsuruda Y, et al.
Surg Today
. 2022 May;
52(12):1721-1730.
PMID: 35543754
Purpose: To investigate the clinical indications and prognostic significance of surgical interventions after chemotherapy using trastuzumab-containing regimens for patients with human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer...
6.
Kobayshi K, Suyama K, Katsuya H, Izawa N, Uenosono Y, Hu Q, et al.
Eur J Cancer
. 2022 Mar;
166:279-286.
PMID: 35349925
Background: The mainstream first-line chemotherapy for advanced/recurrent gastric cancer (ARGC) is combination therapy including platinum-based agents. With the progressive aging of the society, the incidence of gastric cancer in elderly...
7.
Arigami T, Matsushita D, Okubo K, Tanaka T, Sasaki K, Tsuruda Y, et al.
In Vivo
. 2022 Jan;
36(1):409-415.
PMID: 34972742
Background/aim: To investigate changes in post-progression chemotherapy (PPC) before and after nivolumab approval and determine their prognostic impact. Patients And Methods: A total of 146 patients with unresectable gastric cancer...
8.
Nakada K, Ikeda M, Takahashi M, Kinami S, Yoshida M, Uenosono Y, et al.
World J Gastrointest Surg
. 2021 Dec;
13(11):1484-1496.
PMID: 34950435
Background: Defecation disorders are obscure sequelae that occurs after gastrectomy, and its implication on daily lives of patients have not been sufficiently investigated. Aim: To examine the features of defecation...
9.
Lee S, Kaji M, Uenosono Y, Kano M, Shimizu H, Noguchi T, et al.
Surg Today
. 2021 Nov;
52(5):832-843.
PMID: 34734320
Purpose: This retrospective nationwide survey investigated the quality of life (QOL) of patients with esophagogastric junction cancer after gastrectomy using the Postgastrectomy Syndrome Assessment Scale-45. Methods: The Postgastrectomy Syndrome Assessment...
10.
Okubo K, Arigami T, Matsushita D, Uenosono Y, Yanagita S, Kijima T, et al.
Anticancer Res
. 2021 Nov;
41(11):5643-5649.
PMID: 34732437
Background/aim: The clinical benefit of conversion surgery (CS) after chemotherapy remains unclear for stage IV gastric cancer (GC) patients. This study aimed to investigate the prognostic factors used to determine...